IP Library › Patent Application 17465541
Patent Application
App. No. 17/465,541

OXYGEN LINKED PYRIMIDINE DERIVATIVES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/465,541
Abstract

The present invention relates to pyrimidine compounds that are useful as anti-proliferative agents. More particularly, the present invention relates to oxygen linked and substituted pyrimidine compounds, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of proliferative disorders. These compounds may be useful as medicaments for the treatment of a number of proliferative disorders including tumours and cancers as well as other disorders or conditions related to or associated with kinases.

Claims (2)

1 .- 138 . (canceled)

139 . A compound having a structure according to the following formula:

Assignments (4)
MERGER Recorded Oct 3, 2024
From: CTI BIOPHARMA CORP.
To: SOBI, INC.
Reel/Frame 068782/0512 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2022
From: BLANCHARD, STEPHANIE; LEE, CHENG HSIA ANGELINE; NAGARAJ, HARISH KUMAR MYSORE; POULSEN, ANDERS; SUN, ERIC T.; TAN, YEE LING EVELYN; WILLIAM, ANTHONY DEODAUNIA
To: S*BIO PTE LTD.
Reel/Frame 061245/0916 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2022
From: S*BIO PTE LTD.
To: CELL THERAPEUTICS, INC.
Reel/Frame 061245/0934 →
CHANGE OF NAME Recorded Sep 28, 2022
From: CELL THERAPEUTICS, INC.
To: CTI BIOPHARMA CORP.
Reel/Frame 061568/0976 →